ICD-10 Coordination and Maintenance (C&M) Committee Meeting National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting, 11577-11578 [2017-03627]
Download as PDF
11577
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
in early intervention services before six
months of age for those identified with
hearing loss.
Federal support for identifying
children with hearing loss began with
the Children’s Health Act of 2000,
which authorized federal programs to
support EHDI activities at the state
level. Since then, funds have been
distributed to states via cooperative
agreements from the CDC and grants
from the Health Resources and Services
Administration (HRSA). States are using
these federal monies to enhance EHDI
programs and develop corresponding
tracking and surveillance systems.
These systems are intended to help
EHDI programs ensure infants and
children are receiving recommended
hearing screening, follow-up, and
intervention services.
The mission of the CDC EHDI team is
for every state and U.S. territory to have
a complete EHDI tracking and
surveillance system that will help
ensure infants and children with
hearing loss achieve communication
and social skills commensurate with
their cognitive abilities. As part of this
mission the CDC EHDI team, in
collaboration with representatives of
state and U.S. territorial EHDI programs,
developed seven National EHDI Goals
that reflect the ‘‘1–3–6 plan’’ and
address integration with the medical
home (coordinated care by a medical
provider) and development of tracking
and surveillance systems to minimize
loss to follow-up and loss to
documentation. Many of the defined
performance indicators for these goals
involve obtaining data related to the
number of children screened for hearing
loss, referred for and receiving followup testing (e.g., diagnostic audiologic
evaluation) and enrolled in early
intervention services.
The purpose of the revised survey is
to obtain annual state data on the
performance indicators in a consistent
manner, which is needed to assess
progress towards meeting the National
EHDI goals. In addition, the availability
of these data will better enable the CDC
EHDI team to provide technical
assistance to states and respond to
questions by the general public, policy
makers, and Healthy People 2020
officials.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
EHDI Program State Program Coordinators Contacted .........
EHDI Program State Program Coordinators who return the
survey.
Survey Directions ...................
Survey ....................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–03593 Filed 2–23–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcements
(FOAs): CK17–001, ‘‘Creation of a
Healthcare-Associated Infectious
Disease Modeling Network to Improve
Prevention Research and Healthcare
Delivery’’; CK17–002, ‘‘Evaluation of
Clinical Interventions, Surveillance, and
Ecological Factors that Influence the
Burden of Human Monkeypox in the
Democratic Republic of the Congo
(DRC)’’; and CK17–004, ‘‘Determining
VerDate Sep<11>2014
17:20 Feb 23, 2017
Jkt 241001
and Monitoring Health Conditions
Identified in the Medical Assessment of
US-Bound Refugees.’’
Time and Date:
10:00 a.m.–5:00 p.m., EDT, March 28–
29, 2017 (Closed)
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Creation of a Healthcare-Associated
Infectious Disease Modeling Network to
Improve Prevention Research and
Healthcare Delivery’’, CK17–001;
‘‘Evaluation of Clinical Interventions,
Surveillance, and Ecological Factors
that Influence the Burden of Human
Monkeypox in the Democratic Republic
of the Congo (DRC)’’, CK17–002; and
‘‘Determining and Monitoring Health
Conditions Identified in the Medical
Assessment of US-Bound Refugees’’,
CK17–004.
Contact Person for More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
59
57
Average
burden per
response
(in hours)
1
1
10/60
240/60
Georgia 30333, Telephone: (404) 718–
8833.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–03647 Filed 2–23–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
ICD–10 Coordination and Maintenance
(C&M) Committee Meeting National
Center for Health Statistics (NCHS),
Classifications and Public Health Data
Standards Staff, Announces the
Following Meeting
ICD–10 Coordination and
Maintenance (C&M) Committee meeting.
TIME AND DATE: 9:00 a.m.–5:00 p.m.,
EST, March 7–8, 2017
NAME:
E:\FR\FM\24FEN1.SGM
24FEN1
11578
Federal Register / Vol. 82, No. 36 / Friday, February 24, 2017 / Notices
Centers for Medicare and
Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore,
Maryland 21244
STATUS: Open to the public, limited only
by the space available. The meeting
room accommodates approximately 240
people. We will be broadcasting the
meeting live via Webcast at https://
www.cms.gov/live/.
SECURITY CONSIDERATIONS: Due to
increased security requirements CMS
has instituted stringent procedures for
entrance into the building by nongovernment employees. Attendees will
need to present valid government-issued
picture identification, and sign-in at the
security desk upon entering the
building.
Attendees who wish to attend the
March 7–8, 2017 ICD–10–CM C&M
meeting must submit their name and
organization by February 24, 2016 for
inclusion on the visitor list. This visitor
list will be maintained at the front desk
of the CMS building and used by the
guards to admit visitors to the meeting.
Participants who attended previous
Coordination and Maintenance meetings
will no longer be automatically added to
the visitor list. You must request
inclusion of your name prior to each
meeting you wish attend.
Please register to attend the meeting
on-line at: https://www.cms.hhs.gov/
apps/events/. Please contact Mady Hue
(410–786–4510 or Marilu.hue@
cms.hhs.gov), for questions about the
registration process.
PURPOSE: The ICD–10 Coordination and
Maintenance (C&M) Committee is a
public forum for the presentation of
proposed modifications to the
International Classification of Diseases,
Tenth Revision, Clinical Modification
and ICD–10 Procedure Coding System.
MATTERS FOR DISCUSSION: Agenda items
include:
March 7–8, 2017
ICD–10–PCS Topics:
Cerebral Embolic Protection During
Transcatheter Aortic Valve
Replacement
Renal Replacement Therapy
Magnetically Controlled Growth Rods
Oxidized Zirconium Polyethylene
Implant for Hip and Knee
Replacement
Endovascular Intracranial
Thrombectomy
Procedures/Techniques
Radiotherapeutic Brain Implant
Combined Thoracic Arch
Replacement and Thoracic Aorta
Restriction
Occlusion of Left Atrial Appendage
Spinal Fusion with Radiolucent
Interbody Fusion Device
asabaliauskas on DSK3SPTVN1PROD with NOTICES
PLACE:
VerDate Sep<11>2014
17:20 Feb 23, 2017
Jkt 241001
Administration of ZINPLAVA
(Bezlotoxumab)
Administration of VYXEOS
Administration of KTE–C19
(axicabtageneciloleucel) Congenital
Anomaly Procedures
Resection of the Left Ventricular
Outflow Tract Obstruction and/or
Subaortic Membrane(Stenosis)
Fontan Completion Procedure, Stage
II
Alfieri Stitch
Valvuloplasty
Ligation of Pulmonary Trunk
Fluoroscopy of Pulmonary Trunk
Modified Blalock-Taussig Shunt
Release of Myocardial Bridge
Addenda and Key Updates
ICD–10–CM Diagnosis Topics:
Acute Appendicitis
Antenatal Screening
Asthma
Atrial Fibrillation (AF)
Cyclic Vomiting
Diverticular Disease of Intestine
Encounter for examination of eyes and
vision with abnormal findings
Fetal Inflammatory Response
Syndrome
Hepatic Encephalopathy (representation)
Lacunar Infarction
Meibomian Gland Dysfunction
Neonatal Encephalopathy
Glasgow Coma Scale, Pediatric
Personal History of Mesothelioma and
Secondary Mesothelioma
Post Endometrial Ablation Syndrome
Sickle Cell w/o Acute Chest
Syndrome or Splenic Sequestration
Surgical Site Infection
Types of Myocardial Infarctions (MI)
ICD–10–CM Addendum
Agenda items are subject to change as
priorities dictate.
Note: CMS and NCHS no longer
provide paper copies of handouts for the
meeting. Electronic copies of all meeting
materials will be posted on the CMS and
NCHS Web sites prior to the meeting at
https://www.cms.hhs.gov/
ICD9ProviderDiagnosticCodes/03_
meetings.asp#TopOfPage and https://
www.cdc.gov/nchs/icd/icd9cm_
maintenance.htm.
CONTACT PERSONS FOR ADDITIONAL
INFORMATION: Donna Pickett, Medical
Systems Administrator, Classifications
and Public Health Data Standards Staff,
NCHS, 3311 Toledo Road Hyattsville,
Maryland 20782, email dfp4@cdc.gov,
telephone 301–458–4434 (diagnosis);
Mady Hue, Health Insurance Specialist,
Division of Acute Care, CMS, 7500
Security Boulevard, Baltimore,
Maryland, 21244, email marilu.hue@
cms.hhs.gov, telephone 410–786–4510
(procedures).
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–03627 Filed 2–23–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of application in response to
Funding Opportunity Announcement
(FOA) PAR 15–361, NIOSH Centers of
Excellence for Total Worker Health
(TWH).
Time and Date: 1:00 p.m.–6:00 p.m.,
EDT, March 21, 2017 (Closed).
Place: Via Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘NIOSH Centers of Excellence for Total
Worker Health (TWH)’’, PAR 15–361.
Contact Person for More Information:
Marilyn Ridenour, B.S.N., M.B.A.,
M.P.H., Scientific Review Officer, CDC,
1095 Willowdale Road, Mailstop 1811,
Morgantown, WV Telephone: (304) 285–
5879, DVN7@CDC.GOV .
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
E:\FR\FM\24FEN1.SGM
24FEN1
Agencies
[Federal Register Volume 82, Number 36 (Friday, February 24, 2017)]
[Notices]
[Pages 11577-11578]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-03627]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
ICD-10 Coordination and Maintenance (C&M) Committee Meeting
National Center for Health Statistics (NCHS), Classifications and
Public Health Data Standards Staff, Announces the Following Meeting
Name: ICD-10 Coordination and Maintenance (C&M) Committee meeting.
Time and Date: 9:00 a.m.-5:00 p.m., EST, March 7-8, 2017
[[Page 11578]]
Place: Centers for Medicare and Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore, Maryland 21244
Status: Open to the public, limited only by the space available. The
meeting room accommodates approximately 240 people. We will be
broadcasting the meeting live via Webcast at https://www.cms.gov/live/.
Security Considerations: Due to increased security requirements CMS has
instituted stringent procedures for entrance into the building by non-
government employees. Attendees will need to present valid government-
issued picture identification, and sign-in at the security desk upon
entering the building.
Attendees who wish to attend the March 7-8, 2017 ICD-10-CM C&M
meeting must submit their name and organization by February 24, 2016
for inclusion on the visitor list. This visitor list will be maintained
at the front desk of the CMS building and used by the guards to admit
visitors to the meeting.
Participants who attended previous Coordination and Maintenance
meetings will no longer be automatically added to the visitor list. You
must request inclusion of your name prior to each meeting you wish
attend.
Please register to attend the meeting on-line at: https://www.cms.hhs.gov/apps/events/. Please contact Mady Hue (410-786-4510 or
Marilu.hue@cms.hhs.gov), for questions about the registration process.
Purpose: The ICD-10 Coordination and Maintenance (C&M) Committee is a
public forum for the presentation of proposed modifications to the
International Classification of Diseases, Tenth Revision, Clinical
Modification and ICD-10 Procedure Coding System.
Matters for Discussion: Agenda items include:
March 7-8, 2017
ICD-10-PCS Topics:
Cerebral Embolic Protection During Transcatheter Aortic Valve
Replacement
Renal Replacement Therapy
Magnetically Controlled Growth Rods
Oxidized Zirconium Polyethylene Implant for Hip and Knee
Replacement
Endovascular Intracranial Thrombectomy
Procedures/Techniques
Radiotherapeutic Brain Implant
Combined Thoracic Arch Replacement and Thoracic Aorta Restriction
Occlusion of Left Atrial Appendage
Spinal Fusion with Radiolucent Interbody Fusion Device
Administration of ZINPLAVA (Bezlotoxumab)
Administration of VYXEOS
Administration of KTE-C19 (axicabtageneciloleucel) Congenital
Anomaly Procedures
Resection of the Left Ventricular
Outflow Tract Obstruction and/or Subaortic Membrane(Stenosis)
Fontan Completion Procedure, Stage II
Alfieri Stitch
Valvuloplasty
Ligation of Pulmonary Trunk
Fluoroscopy of Pulmonary Trunk
Modified Blalock-Taussig Shunt
Release of Myocardial Bridge
Addenda and Key Updates
ICD-10-CM Diagnosis Topics:
Acute Appendicitis
Antenatal Screening
Asthma
Atrial Fibrillation (AF)
Cyclic Vomiting
Diverticular Disease of Intestine
Encounter for examination of eyes and vision with abnormal findings
Fetal Inflammatory Response Syndrome
Hepatic Encephalopathy (re-presentation)
Lacunar Infarction
Meibomian Gland Dysfunction
Neonatal Encephalopathy
Glasgow Coma Scale, Pediatric
Personal History of Mesothelioma and Secondary Mesothelioma
Post Endometrial Ablation Syndrome
Sickle Cell w/o Acute Chest Syndrome or Splenic Sequestration
Surgical Site Infection
Types of Myocardial Infarctions (MI)
ICD-10-CM Addendum
Agenda items are subject to change as priorities dictate.
Note: CMS and NCHS no longer provide paper copies of handouts for
the meeting. Electronic copies of all meeting materials will be posted
on the CMS and NCHS Web sites prior to the meeting at https://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage
and https://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm.
Contact Persons for Additional Information: Donna Pickett, Medical
Systems Administrator, Classifications and Public Health Data Standards
Staff, NCHS, 3311 Toledo Road Hyattsville, Maryland 20782, email
dfp4@cdc.gov, telephone 301-458-4434 (diagnosis); Mady Hue, Health
Insurance Specialist, Division of Acute Care, CMS, 7500 Security
Boulevard, Baltimore, Maryland, 21244, email marilu.hue@cms.hhs.gov,
telephone 410-786-4510 (procedures).
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-03627 Filed 2-23-17; 8:45 am]
BILLING CODE 4163-18-P